Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
CNSP CNS Pharmaceuticals
- 0.1080
- -0.0020-1.82%
Close Dec 20 16:00 ET
- 0.1124
- +0.0044+4.07%
Post 20:01 ET
6.21MMarket Cap0.00P/E (TTM)
0.1200High0.1008Low4.81MVolume0.1050Open0.1100Pre Close528.01KTurnover8.52%Turnover Ratio0.00P/E (Static)57.49MShares70.000052wk High1.86P/B6.09MFloat Cap0.095552wk Low--Dividend TTM56.38MShs Float8534.8500Historical High--Div YieldTTM17.46%Amplitude0.0950Historical Low0.1090Avg Price1Lot Size
CNS Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 666.66%6.97M | -65.14%1.49M | -84.05%815.23K | -94.54%548.72K | -94.54%548.72K | -87.06%909.55K | -52.23%4.28M | -58.92%5.11M | 100.93%10.06M | 100.93%10.06M |
| -Cash and cash equivalents | 666.66%6.97M | -65.14%1.49M | -84.05%815.23K | -94.54%548.72K | -94.54%548.72K | -87.06%909.55K | -52.23%4.28M | -58.92%5.11M | 100.93%10.06M | 100.93%10.06M |
| Current deferred assets | --26.93K | --16.75K | --0 | --202.86K | --202.86K | ---- | ---- | ---- | --0 | --0 |
| Other current assets | -66.32%388.04K | -64.44%637.09K | -57.78%786.05K | -66.54%839.59K | -66.54%839.59K | -31.12%1.15M | -26.52%1.79M | -18.80%1.86M | 1.47%2.51M | 1.47%2.51M |
| Total current assets | 258.32%7.39M | -64.66%2.15M | -77.03%1.6M | -87.34%1.59M | -87.34%1.59M | -76.30%2.06M | -46.73%6.07M | -52.68%6.97M | 68.03%12.56M | 68.03%12.56M |
| Non current assets | ||||||||||
| Net PPE | -19.25%2.8K | 5.06%3.55K | -1.82%4.31K | -12.91%4.93K | -12.91%4.93K | -59.28%3.47K | -69.17%3.38K | -65.56%4.39K | -64.84%5.66K | -64.84%5.66K |
| Non current prepaid assets | -93.01%18.37K | -15.08%320.32K | -87.38%55.3K | -78.30%104.75K | -78.30%104.75K | -55.84%262.73K | -46.48%377.2K | -44.67%438.13K | -48.07%482.81K | -48.07%482.81K |
| Total non current assets | -92.05%21.18K | -14.90%323.87K | -86.53%59.6K | -77.55%109.68K | -77.55%109.68K | -71.61%266.2K | -63.75%380.58K | -61.14%442.52K | -61.84%488.47K | -61.84%488.47K |
| Total assets | 218.26%7.41M | -61.73%2.47M | -77.60%1.66M | -86.97%1.7M | -86.97%1.7M | -75.84%2.33M | -48.17%6.45M | -53.28%7.41M | 49.05%13.05M | 49.05%13.05M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | ---- | ---- | ---- | ---- | ---- | 300.67%4.03M | 627.39%3.57M | 467.80%2.78M | ---- | ---- |
| -accounts payable | ---- | ---- | ---- | ---- | ---- | 300.67%4.03M | 627.39%3.57M | 467.80%2.78M | ---- | ---- |
| Current accrued expenses | ---- | ---- | ---- | ---- | ---- | ---- | -5.94%260.14K | 177.91%853.23K | ---- | ---- |
| Current debt and capital lease obligation | -25.58%31.19K | -25.93%123.25K | -26.28%213.1K | -26.63%300.81K | -26.63%300.81K | 6.73%41.9K | 6.39%166.4K | 6.05%289.08K | 5.72%409.97K | 5.72%409.97K |
| -Current debt | -25.58%31.19K | -25.93%123.25K | -26.28%213.1K | -26.63%300.81K | -26.63%300.81K | 6.73%41.9K | 6.39%166.4K | 6.05%289.08K | 5.72%409.97K | 5.72%409.97K |
| Current liabilities | -0.29%4.06M | 69.19%6.76M | 55.28%6.09M | 24.65%6.13M | 24.65%6.13M | 226.99%4.07M | 332.66%4M | 266.87%3.92M | 89.66%4.92M | 89.66%4.92M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -0.29%4.06M | 69.19%6.76M | 55.28%6.09M | 24.65%6.13M | 24.65%6.13M | 226.99%4.07M | 332.66%4M | 266.87%3.92M | 89.66%4.92M | 89.66%4.92M |
| Shareholders'equity | ||||||||||
| Share capital | 695.01%33.45K | -65.15%1.44K | 379.29%10.67K | 284.29%6.21K | 284.29%6.21K | -89.49%4.21K | -89.66%4.14K | -94.44%2.23K | 70.39%1.62K | 70.39%1.62K |
| -common stock | 695.01%33.45K | -65.15%1.44K | 379.29%10.67K | 284.29%6.21K | 284.29%6.21K | -89.49%4.21K | -89.66%4.14K | -94.44%2.23K | 70.39%1.62K | 70.39%1.62K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -26.57%-81.25M | -26.77%-75.64M | -31.38%-73.11M | -37.17%-69.57M | -37.17%-69.57M | -43.44%-64.19M | -44.36%-59.67M | -47.34%-55.65M | -43.10%-50.72M | -43.10%-50.72M |
| Paid-in capital | 35.42%84.57M | 14.86%71.35M | 16.12%68.67M | 10.67%65.13M | 10.67%65.13M | 17.59%62.45M | 17.61%62.12M | 12.58%59.14M | 41.45%58.85M | 41.45%58.85M |
| Total stockholders'equity | 292.58%3.35M | -274.93%-4.29M | -226.88%-4.43M | -154.50%-4.43M | -154.50%-4.43M | -120.74%-1.74M | -78.70%2.45M | -76.41%3.49M | 31.96%8.13M | 31.96%8.13M |
| Total equity | 292.58%3.35M | -274.93%-4.29M | -226.88%-4.43M | -154.50%-4.43M | -154.50%-4.43M | -120.74%-1.74M | -78.70%2.45M | -76.41%3.49M | 31.96%8.13M | 31.96%8.13M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |